MARIA SITGES BERRONDO



DATOS GENERALES
Nombre completo   MARIA SITGES BERRONDO
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   30 años
NOMBRAMIENTOS
Último  INVESTIGADOR TITULAR C TC Definitivo
Instituto de Investigaciones Biomédicas
INVESTIGADOR TITULAR C TC Definitivo
Instituto de Investigaciones Biomédicas
Desde 01-01-2008 (fecha inicial de registros en el SIIA) hasta 31-12-2016
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI III2014 - 2018
* SNI II - 2013
* PASPA Estancias Sabáticas2015 - 2016

INFORMACIÓN DE PUBLICACIONES
Firmas  
"Herrera-Mundo, N Sitges M. Sitges, M Sitges, Maria SitgesBerrondo, M
ID's SCOPUS  
56000808700 7006509889
Áreas de conocimiento  
Biochemistry & molecular biology Biochemistry and molecular biology Clinical neurology Jcs 2008 Medicine, general and internal
Multidisciplinary sciences Neurosciences Pharmacology & pharmacy Psychiatry Scie jcr
Agricultural and Biological Sciences (miscellaneous) Biochemistry Medicine (miscellaneous) Neurology (clinical) Pharmacology
Coautorías con entidades de la UNAM  
  • Instituto de Investigaciones Biomédicas
Revistas en las que ha publicado  (18):
  1. BRAIN RESEARCH, Países Bajos (1982, 1985, 1990, 2000)
  2. CLINICAL NEUROPHYSIOLOGY, Irlanda (2004, 2007, 2008)
  3. Epilepsia, Estados Unidos America (2011, 2012, 2013, 2014, 2015)
  4. EPILEPSY & BEHAVIOR, Estados Unidos America (2012)
  5. EPILEPSY RESEARCH, Países Bajos (2003, 2004, 2011)
  6. EUROPEAN JOURNAL OF NEUROLOGY, Estados Unidos America (2008, 2010)
  7. EUROPEAN NEUROPSYCHOPHARMACOLOGY, Países Bajos (1998)
  8. EXPERIMENTAL NEUROLOGY, Estados Unidos America (2002)
  9. JOURNAL OF NEURAL TRANSMISSION, Austria (1989)
  10. JOURNAL OF NEUROCHEMISTRY, Estados Unidos America (1984, 1987, 1989, 1993, 2010, 2012, 2013, 2014, 2015)
  11. JOURNAL OF NEUROSCIENCE, Estados Unidos America (1986)
  12. JOURNAL OF NEUROSCIENCE RESEARCH, Estados Unidos America (1994, 1995)
  13. Medicine, Estados Unidos America (2017)
  14. NEUROCHEMICAL RESEARCH, Estados Unidos America (1993, 1995, 1996, 1997, 1998, 1999, 2004, 2009, 2016)
  15. NEUROCHEMISTRY INTERNATIONAL, Reino Unido (1997, 2005, 2006)
  16. Neuropharmacology, Reino Unido (2007)
  17. NEUROSCIENCE LETTERS, Irlanda (2006)
  18. PLOS ONE, Estados Unidos America (2014)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohortCoautor: Sitges M., Fernández-Cruz A., Muñoz P., Sandoval C., et al.2017MedicineWoS-id: 000411460900011
Scopus-id: 2-s2.0-85029773316
3231
2Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na+ and Ca2+ Channels Permeability1ᵉʳ autor: Sitges, Maria, Maria Chiu, Luz, Reed, Ronald C.2016NEUROCHEMICAL RESEARCHWoS-id: 000373860300014
Scopus-id: 2-s2.0-84946430978
3231
3Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine1ᵉʳ autor: Sitges, Maria, Aldana, Blanca Irene, Reed, Ronald Charles2016NEUROCHEMICAL RESEARCHWoS-id: 000376076300017
Scopus-id: 2-s2.0-84969718887
2021
4Sertraline (antidepressant) inhibits 4-AP-induced ionic channel activation more efficiently than several antiepileptic drugs1ᵉʳ autor: Sitges, M, Chiu, L, Reed, RC2015JOURNAL OF NEUROCHEMISTRYWoS-id: 000360206300336
00
5MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF SUSTAINED-RELEASE VINPOCETINE AS ADJUNCTIVE TREATMENT OF FOCAL-ONSET SEIZURESCoautor: SitgesBerrondo, M, GarzaMorales, SJ, PizarroCastellanos, M, BricenoGonzalez, E, et al.2015EpilepsiaWoS-id: 000365756500028
00
6COMPARISON OF THE EFFECTIVENESS OF SERTRALINE, VINPOCETINE AND SEVERAL CONVENTIONAL ANTIEPILEPTIC DRUGS TO INHIBIT THE EPILEPTIFORM EEG ACTIVITY INDUCED BY 4-AMINOPYRIDINE IN THE RAT1ᵉʳ autor: Sitges, M, Aldana, BI, Reed, RC2015EpilepsiaWoS-id: 000365756500626
00
7EFFECTIVENESS OF A 12 H EXTENDED RELEASE FORMULA OF ETHYL-APOVINCAMINIC ACID IN THE CONTROL OF SEIZURES IN PATIENTS WITH REFRACTORY EPILEPSY1ᵉʳ autor: Sitges, M, Garza-Morales, S2014EpilepsiaWoS-id: 000337979300277
20
8EFFECT OF THE ANTI-SEIZURE DRUGS VINPOCETINE, CARBAMAZEPINE AND VALPROIC ACID ON IL-1 beta AND TNF-alpha EXPRESSION IN THE HIPPOCAMPUSCoautor y autor de correspondencia: Sitges, M, Gomez, CD, Buijs, RM2014EpilepsiaWoS-id: 000337979300572
00
9THE ANTIDEPRESSANT SERTRALINE DIMINISH THE EXPRESSION OF IL-1 beta AND TNF-alpha MRNA INDUCED BY SEIZURES IN THE HIPPOCAMPUS1ᵉʳ autor: Sitges, M, Gomez, CD, Aldana, BI2014EpilepsiaWoS-id: 000337979300681
00
10The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1ß and TNF-a expression in rat hippocampus.Coautor y autor de correspondencia: Sitges, M, Gomez, CD, Buijs, RM2014JOURNAL OF NEUROCHEMISTRYWoS-id: 000341820800005
Scopus-id: 2-s2.0-84908249218
7175
11Sertraline reduces IL-1ß and TNF-a mRNA expression and overcomes their rise induced by seizures in the rat hippocampus1ᵉʳ autor: Sitges, M, Gomez, CD, Aldana, BI2014PLOS ONEWoS-id: 000345558100099
Scopus-id: 2-s2.0-84909606645
3839
12Vinpocetine and a-tocopherol prevent the increase in da and oxidative stress induced by 3-NPA in striatum isolated nerve endings1ᵉʳ autor: "Herrera-Mundo, N, Sitges, M"2013JOURNAL OF NEUROCHEMISTRYWoS-id: 000313260200008
Scopus-id: 2-s2.0-84871614026
2121
13Antiepileptic drugs diminish the expression of IL-1b and TNF-a mRNA induced by seizures in the rat hippocampusCoautor y autor de correspondencia: Sitges, M, Gomez, CD, Buijs, RM2013JOURNAL OF NEUROCHEMISTRYWoS-id: 000316961700246
00
14Vinpocetine and alpha-tocopherol prevent 3-NPA-induced increase in DA and oxidative stress in striatum isolated nerve endings1ᵉʳ autor: Sitges, M, Herrera-Mundo, N2013JOURNAL OF NEUROCHEMISTRYWoS-id: 000316961700407
00
15THE ANTIDEPRESSANT SERTRALINE DIMINISH THE EXPRESSION OF IL-1 beta AND TNF-alpha MRNA INDUCED BY SEIZURES IN THE RAT HIPPOCAMPUS1ᵉʳ autor: Sitges, M, Gomez, CD, Aldana, BI2013EpilepsiaWoS-id: 000320472000133
00
16OPPOSITE EFFECTS OF ANTI-SEIZURE AND PRO-SEIZURE DRUGS ON IL-1 beta AND TNF-alpha MRNA EXPRESSION IN THE HIPPOCAMPUSCoautor y autor de correspondencia: Sitges, M, Gomez, CD, Buijs, RM2013EpilepsiaWoS-id: 000320472001423
00
17SERTRALINE INHIBITS PRE-SYNAPTIC NA(+) CHANNEL-MEDIATED RESPONSES IN HIPPOCAMPUS ISOLATED NERVE ENDINGS2ᵒ autor y autor de correspondencia: Sitges, M, Aldana, BI2013EpilepsiaWoS-id: 000320472001424
00
18Sertraline inhibits pre-synaptic Na plus channel-mediated responses in hippocampus-isolated nerve endings2ᵒ autor y autor de correspondencia: Sitges, M, Aldana, BI2012JOURNAL OF NEUROCHEMISTRYWoS-id: 000302536100003
Scopus-id: 2-s2.0-84859642225
2222
19ANTI-SEIZURE ACTION OF THE ANTIDEPRESSANT, SERTRALINE1ᵉʳ autor: Sitges, M, Aldana, BI2012EpilepsiaWoS-id: 000308875900354
00
20The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures1ᵉʳ autor: Sitges, M, Aldana, BI, Gomez, CD, Nekrassov, V2012EPILEPSY & BEHAVIORWoS-id: 000311784200008
Scopus-id: 2-s2.0-84871831548
2221
21ADJUNCTIVE THERAPY WITH VINPOCETIN IN CHILDREN WITH REFRACTORY PARTIAL EPILEPSY: A PILOT STUDY IN MEXICOCoautor: Sitges, M, Garza-Morales, S, Hernandez-Hernandez, M, Rodriguez-Chicatti, D, et al.2011EpilepsiaWoS-id: 000294217200351
00
22Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs1ᵉʳ autor: Sitges, M, Sanchez-Tafolla, BM, Chiu, LM, Aldana, BI, et al.2011EPILEPSY RESEARCHWoS-id: 000296690200007
Scopus-id: 2-s2.0-80053917195
2222
23Mechanisms underlying striatal vulnerability to 3-nitropropionic acid2ᵒ autor y autor de correspondencia: Sitges, M, Herrera-Mundo, N2010JOURNAL OF NEUROCHEMISTRYWoS-id: 000279077900024
Scopus-id: 2-s2.0-77953823297
1517
24Effect of antiepileptic drugs on the rise in Ca2+ induced by 4-aminopyridine in cerebral isolated nerve endings: a strategy for screening new potential anticonvulsants1ᵉʳ autor: Sitges, M, Sanchez-Tafolla, BM, Aldana, BI2010EUROPEAN JOURNAL OF NEUROLOGYWoS-id: 000293331100343
00
25Hearing and antiepileptic treatment2ᵒ autor y autor de correspondencia: Sitges, M, Nekrassov, V2010EUROPEAN JOURNAL OF NEUROLOGYWoS-id: 000293331100366
00
26Effect of various classical and potential antiepileptic drugs on glutamate release elicited by the convulsive agent 4-aminopyridine in nerve endings isolated from the hippocampu1ᵉʳ autor: Sitges, M, Sanchez-Tafolla, BM, Chiu, LM, Nekrassov, V2010EUROPEAN JOURNAL OF NEUROLOGYWoS-id: 000293331100367
00
27Characterization of Phenytoin, Carbamazepine, Vinpocetine and Clorgyline Simultaneous Effects on Sodium Channels and Catecholamine Metabolism in Rat Striatal Nerve Endings1ᵉʳ autor: Sitges M., Aldana B.I., Chiu L.M., Nekrassov V.2009NEUROCHEMICAL RESEARCHWoS-id: 000263148200011
Scopus-id: 2-s2.0-59849118877
55
28Additive effects of antiepileptic drugs and pentylenetetrazole on hearing2ᵒ autor y autor de correspondencia: Sitges, M, Nekrassov, V2008EUROPEAN JOURNAL OF NEUROLOGYWoS-id: 000258379000306
00
29Comparison of carbamazepine, phenytoin, valproate, oxcarbazepine, lamotrigine, topiramate and vinpocetine effects on sodium and calcium channel-mediated release of glutamate in1ᵉʳ autor: Sitges, M, Chiu, LM, Guarneros, A, Nekrassov, V2008EUROPEAN JOURNAL OF NEUROLOGYWoS-id: 000258379001018
00
30Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine2ᵒ autor y autor de correspondencia: Sitges M., Nekrassov V.2008CLINICAL NEUROPHYSIOLOGYWoS-id: 000261257900025
Scopus-id: 2-s2.0-54149084727
910
31Acute and chronic effects of carbamazepine, phenytoin, valproate and vinpocetine on BAEP parameters and threshold in the guinea pig1ᵉʳ autor: Sitges M., Nekrassov V.2007CLINICAL NEUROPHYSIOLOGYWoS-id: 000244135200021
Scopus-id: 2-s2.0-33845958598
69
32Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings1ᵉʳ autor: Sitges M., Chiu L.M., Guarneros A., Nekrassov V.2007NeuropharmacologyWoS-id: 000244595500039
Scopus-id: 2-s2.0-33846487961
6673
33Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: Comparison with the Na+ channel-mediated release1ᵉʳ autor: Sitges M., Guarneros A., Nekrassov V.2007NeuropharmacologyWoS-id: 000251536100007
Scopus-id: 2-s2.0-35648948354
5655
34Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings1ᵉʳ autor: Sitges M., Chiu L.M., Nekrassov V.2006NEUROCHEMISTRY INTERNATIONALWoS-id: 000238641800006
Scopus-id: 2-s2.0-33747624158
2222
35Additive effects of antiepileptic drugs and pentylenetetrazole on hearing2ᵒ autor y autor de correspondencia: Sitges M., Nekrassov V.2006NEUROSCIENCE LETTERSWoS-id: 000240998700025
Scopus-id: 2-s2.0-33748201083
1414
36?-Agatoxin-TK is a useful tool to study P-type Ca 2+ channel-mediated changes in internal Ca 2+ and glutamate release in depolarised brain nerve terminals1ᵉʳ autor: Sitges M., Galindo C.A.2005NEUROCHEMISTRY INTERNATIONALWoS-id: 000226266600006
Scopus-id: 2-s2.0-9644303215
1819
37Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes1ᵉʳ autor: Sitges M., Galván E., Nekrassov V.2005NEUROCHEMISTRY INTERNATIONALWoS-id: 000228944500003
Scopus-id: 2-s2.0-17444415714
5152
38Characterization of the Participation of Sodium Channels on the Rise in Na+ Induced by 4-Aminopyridine (4-AP) in Synaptosomes2ᵒ autor y autor de correspondencia: Sitges M., Galván E.2004NEUROCHEMICAL RESEARCHWoS-id: 000188610000003
Scopus-id: 2-s2.0-1242336754
2120
39Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo2ᵒ autor y autor de correspondencia: Sitges M., Nekrassov V.2004EPILEPSY RESEARCHWoS-id: 000223417500007
Scopus-id: 2-s2.0-3242814482
1918
40Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing1ᵉʳ autor: Sitges M., Nekrassov V.2004CLINICAL NEUROPHYSIOLOGYWoS-id: 000225540600005
Scopus-id: 2-s2.0-8844267715
1718
41Dihydropiridines Mechanism of Action in Striatal Isolated Nerve Endings: Comparison with ?-Agatoxin IVA2ᵒ autor y autor de correspondencia: Sitges M., Galindo C.A.2004NEUROCHEMICAL RESEARCHScopus-id: 2-s2.0-1842507926
1719
42Effects of pentylenetetrazole and 4-aminopyridine on the auditory brainstem response (ABR) and on the hearing sensitivity in the guinea pig in vivo2ᵒ autor y autor de correspondencia: Sitges M., Nekrassov V.2003EPILEPSY RESEARCHWoS-id: 000182635600010
Scopus-id: 2-s2.0-0037360743
1111
43The expression of GABA in mossy fiber synaptosomes coincides with the seizure-induced expression of GABAergic transmission in the mossy fiber synapseCoautor: Sitges M., Gómez-Lira G., Trillo E., Ramírez M., et al.2002EXPERIMENTAL NEUROLOGYWoS-id: 000178263600025
Scopus-id: 2-s2.0-0036435650
2929
44Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings1ᵉʳ autor: Sitges M., Nekrassov V., Guarneros A.2000BRAIN RESEARCHWoS-id: 000085122300008
Scopus-id: 2-s2.0-0033978296
2930
45Vinpocetine protects from aminoglycoside antibiotic-induced hearing loss in guinea pig in vivo2ᵒ autor y autor de correspondencia: Sitges M., Nekrassov V.2000BRAIN RESEARCHWoS-id: 000087789300006
Scopus-id: 2-s2.0-0034705771
1820
46Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation1ᵉʳ autor: Sitges M., Nekrassov V.1999NEUROCHEMICAL RESEARCHWoS-id: 000083822500013
Scopus-id: 2-s2.0-0032728570
3334
47Effects of external pH variations on brain presynaptic sodium and calcium channels; repercussion on the evoked release of amino acid neurotransmitters1ᵉʳ autor: Sitges M., Rodríguez R.M.1998NEUROCHEMICAL RESEARCHWoS-id: 000073027200004
Scopus-id: 2-s2.0-0031956268
99
48Chronic verapamil modifies striatal and frontal cortex dopamine levels1ᵉʳ autor: Sitges M., Guarneros A.1998EUROPEAN NEUROPSYCHOPHARMACOLOGYScopus-id: 2-s2.0-0031893203
38
49Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels1ᵉʳ autor: Sitges M., Peña F., Chiu L.M., Guarneros A.1997NEUROCHEMISTRY INTERNATIONALWoS-id: 000072660500007
Scopus-id: 2-s2.0-0031200971
1918
50Characterization of melittin effects in synaptosomesCoautor: Sitges M., González L., Nekrassov V., Castell A.1997NEUROCHEMICAL RESEARCHWoS-id: A1997WF52800012
Scopus-id: 2-s2.0-0031014930
1010
51Nigericin-induced Na+/H+ and K+/H+ exchange in synaptosomes: Effect on [3H]GABA release2ᵒ autor y autor de correspondencia: Sitges M., Rodríguez R.1996NEUROCHEMICAL RESEARCHWoS-id: A1996VL52300004
Scopus-id: 2-s2.0-0029949656
1917
52?-Aga IVA selectively inhibits the calcium-dependent fraction of the evoked release of [3H]GABA from synaptosomes1ᵉʳ autor: Sitges M., Chiu L.M.1995NEUROCHEMICAL RESEARCHWoS-id: A1995RX66400013
Scopus-id: 2-s2.0-0028846714
2019
53Characterization of the type of calcium channel primarily regulating GABA exocytosis from brain nerve endings1ᵉʳ autor: Sitges M., Chiu L.M.1995NEUROCHEMICAL RESEARCHWoS-id: A1995RX66400014
Scopus-id: 2-s2.0-0028885551
814
54Effects of verapamil on the release of different neurotransmitters1ᵉʳ autor: Sitges M., Reyes A.1995JOURNAL OF NEUROSCIENCE RESEARCHWoS-id: A1995QQ44200005
Scopus-id: 2-s2.0-0028918913
1414
55A role for calcium/calmodulin kinase(s) in the regulation of GABA exocytosis1ᵉʳ autor: Sitges M., Dunkley P.R., Chiu L.M.1995NEUROCHEMICAL RESEARCHWoS-id: A1995QQ06300001
Scopus-id: 2-s2.0-0028965414
1218
56Dopamine transporter mediated release of dopamine: Role of chloride1ᵉʳ autor: Sitges M., Reyes A., Chiu L.M.1994JOURNAL OF NEUROSCIENCE RESEARCHWoS-id: A1994PF02700002
Scopus-id: 2-s2.0-0027965684
1919
57Sphingosine, W-7, and trifluoperazine inhibit the elevation in cytosolic calcium induced by high K+ depolarization in synaptosomes1ᵉʳ autor: Sitges M., Talamo B.R.1993JOURNAL OF NEUROCHEMISTRYWoS-id: A1993LM75300005
Scopus-id: 2-s2.0-0027244481
2525
58Vesicular and carrier-mediatied depolarization-induced release of [3H]GABA: Inhibition by amiloride and verapamil1ᵉʳ autor: Sitges M., Chiu L.M., González L.1993NEUROCHEMICAL RESEARCHWoS-id: A1993MB61300008
Scopus-id: 2-s2.0-0027519715
1817
59The effect of verapamil on GABA and dopamine release does not involve voltage-sensitive calcium channels1ᵉʳ autor: Sitges M., María Chiu L., de la Fuente J.R.1990BRAIN RESEARCHWoS-id: A1990EL64300007
Scopus-id: 2-s2.0-0025226503
2221
60Effect of organic and inorganic calcium channel blockers on ?-amino-n-butyric acid release induced by monensin and veratrine in the absence of external calcium1ᵉʳ autor y autor de correspondencia: Sitges M.1989JOURNAL OF NEUROCHEMISTRYWoS-id: A1989AG08000016
Scopus-id: 2-s2.0-0024373189
3634
61Synthetic peptides corresponding to the sequence of noxiustoxin indicate that the active site of this K+ channel blocker is located on its amino-terminal portionCoautor: Sitges M., Gurrola G.B., Molinar-Rode R., Bayon A., et al.1989JOURNAL OF NEURAL TRANSMISSIONWoS-id: A1989U852800002
Scopus-id: 2-s2.0-0024370375
2930
62Characterization of the effect of monensin on ?-amino-n-butyric acid release from isolated nerve terminals1ᵉʳ autor y autor de correspondencia: Sitges M.1989JOURNAL OF NEUROCHEMISTRYWoS-id: A1989AG08000017
Scopus-id: 2-s2.0-0024352121
1918
63Characterization of the actions of toxins II-9.2.2 and II-10 from the venom of the scorpion Centruroides noxius on transmitter release from mouse brain synaptosomes1ᵉʳ autor: Sitges M., Possani L.D., Bayón A.1987JOURNAL OF NEUROCHEMISTRYWoS-id: A1987H288400012
Scopus-id: 2-s2.0-0023254029
1416
64Noxiustoxin, a short-chain toxin from the Mexican scorpion Centruroides noxius, induces transmitter release by blocking K+ permeability1ᵉʳ autor: Sitges M., Possani L.D., Bayon A.1986JOURNAL OF NEUROSCIENCEWoS-id: A1986C814500005
Scopus-id: 2-s2.0-0022461362
4543
65Mechanism of the calcium-dependent stimulation of transmitter release by 4-aminopyridine in synaptosomes2ᵒ autor: Sitges M., Tapia R., Morales E.1985BRAIN RESEARCHWoS-id: A1985AXK2900040
Scopus-id: 2-s2.0-0022409509
6768
66Stimulation of [3H]?-aminobutyric acid release by calcium chelators in synaptosomes2ᵒ autor: Sitges M., Arias C., Tapia R.1984JOURNAL OF NEUROCHEMISTRYWoS-id: A1984ST80200001
Scopus-id: 2-s2.0-0021288111
4338
67Effect of 4-aminopyridine on transmitter release in synaptosomes2ᵒ autor y autor de correspondencia: Sitges M., Tapia R.1982BRAIN RESEARCHWoS-id: A1982PN29000010
Scopus-id: 2-s2.0-0019907875
108103
Descargar PDF

Documentos no indexados (Humanindex)

# Título del documento ISSN Revista Año Fuente
Descargar PDF

No se encuentran registros en la base de datos de capítulos de libros (WoS y Scopus).

Descargar PDF

No se encuentran registros en la base de datos de obras con ISBN (Indautor).

Descargar PDF

No se encuentran registros en la base de datos de proyectos.

Descargar PDF

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Citocinas proinflamatorias, epilepsia y farmacos antiepilépticosTesis de DoctoradoMARIA SITGES BERRONDO; Gómez Martínez, Carlos Daniel; 2014Instituto de Investigaciones Biomédicas,
2La sertralina reduce la permeabilidad de los canales de sodio en sinaptosomas de hipocampo y las convulsiones en la rata in vivoTesis de DoctoradoMARIA SITGES BERRONDO; Aldana García, Blanca Irene; 2013Instituto de Investigaciones Biomédicas,
3Caracterización de los efectos de varios fármacos antiepilépticos sobre la liberación de glutamato estimulada por 4-aminopiridina en terminales nerviosas aisladas de hipocampo : comparación con el efecto de la vinpocetinaTesis de LicenciaturaMARIA SITGES BERRONDO; Sánchez Tafolla, Berardo Manuel; 2011Instituto de Investigaciones Biomédicas,
4Caracterización del efecto de la dopamina y su metabolismo sobre el estrés oxidativo en el estriadoTesis de DoctoradoJULIO EDUARDO ROQUE MORAN ANDRADE; EMILIO ROJAS DEL CASTILLO; MARIA SITGES BERRONDO; Herrera Mundo, María Nieves; 2011Facultad de Ciencias, Instituto de Fisiología Celular, Instituto de Investigaciones Biomédicas,
5Efecto de las dihidropiridinas y -agatoxinas sobre los cambios ionicos y la liberacion de neurotransmisores inducidos por despolarizacionTesis de DoctoradoMARIA SITGES BERRONDO; Galindo Rosete, Carlos Alberto; 2004
6Efectos de la vinpocentina sobre la distribucion de DA y DOPAC en terminales nerviosas de estriadoTesis de DoctoradoMARIA SITGES BERRONDO; Trejo Islas, Francisco; 2002
7Regulacion de los canales de sodio sensibles a veratridina en sinaptosomasTesis de LicenciaturaMARIA SITGES BERRONDO; Peña Ortega, José Fernando; 1996
8Efectos de la melitina sobre los sinaptosomasTesis de MaestríaMARIA SITGES BERRONDO; Gonzalez de la Garza, Luxiola Margarita; 1995
9Efecto del verapamil sobre la liberacion de neurotransmisores en sinaptosomasTesis de LicenciaturaMARIA SITGES BERRONDO; Chiu Velazquez, Luz Maria; 1990
Descargar PDF

Docencia Impartida

# Entidad Nivel Asignatura Año Semestre Alumnos
1Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 820102010-21
2Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 720092010-11
3Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 620092009-21
4Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 520082009-11
5Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 420082008-21
6Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 820082008-21
7Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 720072008-11
8Facultad de MedicinaLicenciaturaUNIDAD TEORICA 620072008-118
9Facultad de MedicinaLicenciaturaTRABAJO DE INVESTIGACION 320072008-11
Descargar PDF

Patentes Otorgadas

# Título Inventores Año Sección
1USO DE LA VINPOCETINA PARA PREVENIR LAS COMPLICACIONES, PARTICULARMENTE LAS RELACIONADAS CON LA AUDICION, QUE ACOMPAÑAN A LA EPILEPSIA Y SU TRATAMIENTO.MARIA SITGES BERRONDO, 2010HUMAN NECESSITIES
Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)

# Título del libro Título del capítulo ISBN Editorial Año Fuente